Second-Line Gemcitabine Plus Nab-Paclitaxel for Patients with Unresectable Advanced Pancreatic Cancer after First-Line FOLFIRINOX Failure

Abstract

Second-line GnP after FX failure for patients with APC could be more effective than GEM alone. Further comparison studies are warranted.